Carboquone - Docslib

(12) United States Patent (10) Patent No.: US 8,580,267 B2 Pedretti Et Al
Ep 2569287 B1
Aspects of the Usage of Antineoplastic and 1Mmunomodulating Agents in a Section of the Private Health Care Sector
Section B Changed Classes/Guidelines Final
Multistage Delivery of Active Agents
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
(12) Patent Application Publication (10) Pub. No.: US 2005/0196409 A1 Da0 Et Al
WO 2018/096100 Al 31 May 2018 (31.05.2018) W !P O PCT
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHRM 203 Allison Beale Overview
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines1
Comparison of 6-Thioguanine-Resistant Mutation and Sister Chromatid Exchanges in Chinese Hamster V79 Cells with Forty Chemical and Physical Agents
Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing
(12) United States Patent (1O) Patent No.: US 8,173,115 B2 Decuzzi Et Al
(12) Patent Application Publication (10) Pub. No.: US 2014/0200250 A1 Peng Et Al
Drug Metabolism Group
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

Top View